0 results available. Select is focused ,type to refine list, press Down to open the menu,
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products wor...
The following section summarizes insights on Amneal Pharmaceuticals Inc Class A's Net Income to Company:
We've identified the following companies as similar to Amneal Pharmaceuticals Inc Class A because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Income to Company in the financials category include:
This item represents the net income available to all stakeholders of the company and is presented as total income or loss before discontinued operatio...
Amneal Pharmaceuticals reported net income to company of -73.876 M for the latest twelve months ending December 31, 2024 on its income statement.
The tables below summarizes Amneal Pharmaceuticals’s Net Income to Company and common size over the last five years:
| Fiscal Year | Net Income to Company | Revenue | % Revenue |
|---|---|---|---|
| 2020-12-31 | 68.578 M | 1.993 B | 3.4% |
| 2021-12-31 | 20.17 M | 2.094 B | 1.0% |
| 2022-12-31 | -254.8 M | 2.212 B | −11.5% |
| 2023-12-31 | -48.722 M | 2.394 B | −2.0% |
| 2024-12-31 | -73.876 M | 2.794 B | −2.6% |
The tables below summarizes Amneal Pharmaceuticals’s Net Income to Company and common size over the last four quarters:
| Quarter Ending | Net Income to Company | Revenue | % Revenue |
|---|---|---|---|
| 2024-03-31 | -81.678 M | 659.2 M | −12.4% |
| 2024-06-30 | 16.787 M | 701.8 M | 2.4% |
| 2024-09-30 | 11.757 M | 702.5 M | 1.7% |
| 2024-12-31 | -20.742 M | 730.5 M | −2.8% |
The chart above depicts the distribution of net income to company for companies operating in the Healthcare sector in the Developed economic region. Over 2,500 companies were considered in this analysis, and 2,405 had meaningful values. The average net income to company of companies in the sector is 71.666 K with a standard deviation of 151.9 M.
Amneal Pharmaceuticals Inc Class A's Net Income to Company of -73.876 M ranks in the 13.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,505 |
| Included Constituents | 2,405 |
| Min | -372.2 M |
| Max | 1.331 B |
| Median | -5.178 M |
| Mean | 71.666 K |
| Standard Deviation | 151.9 M |
You can find companies with similar net income to company using this stock screener.